China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2013-07-31 01:30 China's SIPO Voids Patent for Gilead's Viread 2013-07-30 01:30 aTyr Pharma of San Diego and Hong Kong Completes $49 Million Venture Round and more... 2013-07-28 01:30 Week in Review: Hisun to Build Manufacturing Facility for Finished Drugs 2013-07-27 01:30 Lumenis to Distribute Visionix's Ophthalmic Products in China and more... 2013-07-26 01:30 Zhejiang Hisun Floats $153 Million of Bonds to Build Finished Drug Facility 2013-07-25 01:30 Legend Capital Participates in JenaValve's $62.5 Million Venture Round and more... 2013-07-24 01:30 GSK in Talks with Potential China Vaccine Partners and more... 2013-07-23 01:30 Hisun and Celsion Sign MOU to Expand ThermoDoxÔö£éÔö¼?½ Collaboration 2013-07-21 01:30 Week in Review: Mindray Closes Acquisition of US Ultrasound Company 2013-07-20 01:30 Mindray Closes Zonare Ultrasound Deal at $101.7 Million and more... 2013-07-19 01:30 Sihuan Pharma Receives OK from CFDA for Trials of Novel PPI Drug 2013-07-18 01:30 Kunming Pharma Starts TCM Joint Venture in Uzbekistan and more... 2013-07-17 01:30 Ministry of Public Security: GSK Spent $489 Million on Bribes in China since 2007 2013-07-16 01:30 Tianyin Pharma Hopes to Sell Azithromycin API in India 2013-07-14 01:30 Week in Review: Kinex Gains China Rights to Hanmi's Orascovery Program 2013-07-13 01:30 Will GSK's China Scandals Diminish Big Pharma's Interest in China R&D? and more... 2013-07-12 01:30 Shenogen Pharma of Beijing Raises $20 Million in C Round and more... 2013-07-11 01:30 Kinex Gains China Rights to Cancer Program from Hanmi and more... 2013-07-10 01:30 Problems with China Trial Data of BMS/Pfizer Blood Thinner Caused Delay in Approval and more... 2013-07-09 01:30 Wuzhou Pharma Awarded Govt. Grant for DelMar Partnership and more... 2013-07-07 01:30 Week in Review: Glaxo Officials in China Detained for "Economic Crimes" 2013-07-06 01:30 China Investigates Pricing Practices of 60 Drugmakers and more... 2013-07-04 01:30 Shanghai RAAS to Acquire Banghe Pharma for $290 Million and more... 2013-07-03 01:30 Pharming Enters Drug Development Pact with Sinopharm Subsidiary 2013-07-02 01:30 GSK Officials in China Detained over Corruption Charges and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC